Cannabis & Psychedelic Conference 2022 - Michael Sassano - CEO & Founder of SOMAÍ Pharmaceuticals

Sequire Cannabis & Psychedelic Conference went live on April 20th with industry experts and investor 1:1s. This 1-day virtual investor event was held via SRAX’s Sequire Virtual Events platform on April 20th, 2022. Nearly nine million active small-cap investors were invited to the event, which featured over 25 Cannabis & Psychedelic companies hosting 25 minute presentations, alongside keynotes highlighting prominent names in these spaces. The conference is one of many industry specific events that Sequire hosts for their budding investor community. ℂ𝕠𝕟𝕟𝕖𝕔𝕥 𝕨𝕚𝕥𝕙 𝕄𝕚𝕔𝕙𝕒𝕖𝕝 𝕊𝕒𝕤𝕤𝕒𝕟𝕠 𝕆𝕟𝕝𝕚𝕟𝕖 » Read Michael’s articles here: https://www.somaipharma.eu/press​ » Follow Michael on LinkedIn: https://www.linkedin.com/in/michaelsassano3/ » Follow Michael on Facebook: https://m.facebook.com/michael.sassano.37 » Follow Michael on Twitter: https://mobile.twitter.com/Michael_Sassano » Follow Michael on Instagram: https://www.instagram.com/mikesassa/?hl=en ℂ𝕠𝕟𝕟𝕖𝕔𝕥 𝕨𝕚𝕥𝕙 𝕊𝕆𝕄𝔸Í ℙ𝕙𝕒𝕣𝕞𝕒𝕔𝕖𝕦𝕥𝕚𝕔𝕒𝕝𝕤 𝕆𝕟𝕝𝕚𝕟𝕖 » Contact us: https://www.somaipharma.eu/#contact » Get our latest news: https://www.somaipharma.eu/press » Follow SOMAÍ on LinkedIn: https://www.linkedin.com/company/somaipharma/ » Follow SOMAÍ on Facebook: https://www.facebook.com/somaipharma/ » Follow SOMAÍ on Twitter: https://twitter.com/somaipharma » Follow SOMAÍ on Instagram: https://www.instagram.com/somaipharma SOMAÍ Pharmaceuticals LTD is an Ireland-based company that focuses on the cultivation and extraction of cannabis, and producing EU-GMP certified cannabinoid formulations for pharmaceutical distribution. SOMAÍ will be positioned as a top global pharmaceutical distributor of medical-grade, EU-GMP-certified cannabis.